Advanced infusion care (aic) now offers takeda's glassia® [alpha1-proteinase inhibitor (human)] and aralast® np [alpha1-proteinase inhibitor (human)]

Dallas--(business wire)--aic, a division of ais healthcare, now offers glassia and aralast np, manufactured by takeda, for the treatment of adult patients with clinically evident emphysema due to severe hereditary deficiency of alpha1-pi (alpha1-antitrypsin deficiency). the nationally accredited home infusion teams at aic collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. the addition of these therapy options e.
TAK Ratings Summary
TAK Quant Ranking